Lincoln National Corp’s CONMED CNMD Stock Holding History

Lincoln National Corp’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,490	Closed	-$203K	–	1030
2023 Q2	$203K	Buy	+1,490	New	+$182K	﹤0.01%	963

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Lincoln National Corp's CNMD Position: Q3 2023 in Review

Lincoln National Corp sold out of CONMED (CNMD) in Q3 2023, closing a stake of 1,490 shares — an estimated $203K sold.

Lincoln National Corp first reported a position in CNMD in Q2 2023 and held it in 1 quarter. The position peaked at $203K in Q2 2023. 275 funds tracked by Wall St. Rank hold CNMD as of Q3 2023.

Lincoln National Corp reported no remaining CONMED position as of Q3 2023 after selling out during the quarter.
Lincoln National Corp sold 1,490 CONMED shares in Q3 2023, an estimated $203K.
Lincoln National Corp first reported a position in CONMED in Q2 2023 and held it in 1 quarter.
Lincoln National Corp's CONMED position peaked at $203K in Q2 2023.
275 funds tracked by Wall St. Rank held CONMED as of Q3 2023.

Based on Lincoln National Corp's 13F filing for Q3 2023, filed 6 Nov 2023.